Evidence for progressive reduction and loss of telocytes in the dermal cellular network of systemic sclerosis
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Telocytes, a peculiar type of stromal cells, have been recently identified in a variety of tissues and organs, including human skin. Systemic sclerosis (SS c, scleroderma) is a complex connective tissue disease characterized by fibrosis of the skin and internal organs. We presently investigated telocyte distribution and features in the skin of SS c patients compared with normal skin. By an integrated immunohistochemical and transmission electron microscopy approach, we confirmed that telocytes were present in human dermis, where they were mainly recognizable by their typical ultrastructural features and were immunophenotypically characterized by CD 34 expression. Our findings also showed that dermal telocytes were immunophenotypically negative for CD 31/PECAM‐1 (endothelial cells), α‐SMA (myofibroblasts, pericytes, vascular smooth muscle cells), CD 11c (dendritic cells, macrophages), CD 90/Thy‐1 (fibroblasts) and c‐kit/CD 117 (mast cells). In normal skin, telocytes were organized to form three‐dimensional networks distributed among collagen bundles and elastic fibres, and surrounded microvessels, nerves and skin adnexa (hair follicles, sebaceous and sweat glands). Telocytes displayed severe ultrastructural damages (swollen mitochondria, cytoplasmic vacuolization, lipofuscinic bodies) suggestive of ischaemia‐induced cell degeneration and were progressively lost from the clinically affected skin of SS c patients. Telocyte damage and loss evolved differently according to SS c subsets and stages, being more rapid and severe in diffuse SS c. Briefly, in human skin telocytes are a distinct stromal cell population. In SS c skin, the progressive loss of telocytes might (i) contribute to the altered three‐dimensional organization of the extracellular matrix, (ii) reduce the control of fibroblast, myofibroblast and mast cell activity, and (iii) impair skin regeneration and/or repair.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Understanding fibrosis in systemic sclerosis: shifting paradigms, emerging opportunities
Bhattacharyya, S., Wei, J., & Varga, J. (2012) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2011.149 · Cited by 381 · cited 2×
“Endothelial cell injury is supposed to be the initial event which together with inflammatory and autoimmune reactions leads to the chronic activation and transdifferentiation of fibroblasts into myofibroblasts, finally resulting in a deregulated wound healing process and severe tissue fibrosis [1, 2, 5].”
BackgroundAsano, Y., Ihn, H., Yamane, K., Jinnin, M., Mimura, Y., & Tamaki, K. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21246 · Cited by 129 · cited 1×
“Indeed, fibroblasts from clinically affected SSc skin cultured in vitro still continue to produce excessive amounts of extracellular matrix proteins, suggesting that once activated, these cells establish a constitutive self-activation system [12, 13].”
BackgroundManetti, M., Neumann, E., Milia, A. F., Tarner, I. H., Bechi, P., Matucci‐Cerinic, M., Ibba‐Manneschi, L., & Müller‐Ladner, U. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22940 · Cited by 82 · cited 2×
“It will be also of high interest to ascertain whether telocyte damage and disappearance is restricted to the skin or it may also occur in the internal organs targeted by the SSc fibrotic process, such as the lung, heart and gastrointestinal tract [2–4, 49–51].”
BackgroundSelf-citation
Cited by
Fibrosis—a lethal component of systemic sclerosis
Ho, Y. Y., Lagares, D., Tager, A. M., & Kapoor, M. (2014) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2014.53 · Cited by 306
Manetti, M., Romano, E., Rosa, I., Guiducci, S., Bellando-Randone, S., De Paulis, A., Ibba-Manneschi, L., & Matucci-Cerinic, M. (2017) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2016-210229 · Cited by 278
Self-citationCretoiu, S. M., & Popescu, L. M. (2014) · Biomolecular Concepts · doi:10.1515/bmc-2014-0029 · Cited by 267
PAI1 mediates fibroblast-mast cell interactions in skin fibrosis
Pincha, N., Hajam, E. Y., Badarinath, K., Batta, S. P. R., Masudi, T., Dey, R., Andreasen, P., Kawakami, T., Samuel, R., George, R., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci99088 · Cited by 70
“The presence of mast cell–adherent fibroblasts in the skin of patients with scleroderma highlights the potential importance of this phenomenon in therapeutic development (42, 67, 68).”
BackgroundStem cells and aberrant signaling of molecular systems in skin aging
Peng, Y., Xuan, M., Leung, V. Y. L., & Cheng, B. (2015) · Ageing Research Reviews · doi:10.1016/j.arr.2014.10.006 · Cited by 35
Metadata
- Authors
- Manetti, M., Guiducci, S., Ruffo, M., Rosa, I., Faussone‐Pellegrini, M. S., Matucci‐Cerinic, M., & Ibba‐Manneschi, L.
- Venue
- Journal of Cellular and Molecular Medicine
- Publisher
- Wiley
- Published
- 2013-02-27
- Volume
- 17
- Issue
- 4
- Pages
- 482-496
- ISSN
- 1582-1838 (ISSN-L)
- 1582-4934
- OpenAlex
- W2088386446
- Cited by
- 155
- References
- 3
- FWCI
- 14.23
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Evidence for progressive reduction and loss of telocytes in the dermal cellular network of systemic sclerosis. https://app.cochat.ai/papers/10.1111/jcmm.12028
- The paper
- Manetti, M., Guiducci, S., Ruffo, M., Rosa, I., Faussone‐Pellegrini, M. S., Matucci‐Cerinic, M., & Ibba‐Manneschi, L. (2013). Evidence for progressive reduction and loss of telocytes in the dermal cellular network of systemic sclerosis. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.12028
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.